当前位置:首页 - 行情中心 - 德展健康(000813) - 财务分析 - 现金流量表

德展健康

(000813)

  

流通市值:72.13亿  总市值:72.14亿
流通股本:20.97亿   总股本:20.97亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金80,060,929.88421,198,891.67339,094,067.94234,078,515.91
  收到的税费返还-513,044.82234,309.63-
  收到其他与经营活动有关的现金39,785,923.4154,572,563.4341,326,129.5925,299,611.47
  经营活动现金流入小计119,846,853.29476,284,499.92380,654,507.16259,378,127.38
  购买商品、接受劳务支付的现金8,320,540.467,313,202.2435,662,171.3419,756,021.47
  支付给职工以及为职工支付的现金59,296,808.5232,606,269.85162,756,597.55111,029,924.64
  支付的各项税费11,159,079.3462,880,229.5641,267,667.4629,569,687.32
  支付其他与经营活动有关的现金24,983,955.56108,762,315.15114,556,92171,219,604.57
  经营活动现金流出小计103,760,383.8471,562,016.8354,243,357.35231,575,238
  经营活动产生的现金流量净额16,086,469.494,722,483.1226,411,149.8127,802,889.38
二、投资活动产生的现金流量:
  收回投资收到的现金3,000,00010,000,0005,000,0005,000,000
  取得投资收益收到的现金-35,101.192,932.822,932.82
  处置固定资产、无形资产和其他长期资产收回的现金净额303,665577,987.66366,067.06227,258.36
  投资活动现金流入小计3,303,66510,613,088.855,368,999.885,230,191.18
  购建固定资产、无形资产和其他长期资产支付的现金80,838,187.75235,988,546.05156,921,325.4699,836,407.8
  投资支付的现金300,000,000460,000,00040,000,00040,000,000
  投资活动现金流出小计380,838,187.75695,988,546.05196,921,325.46139,836,407.8
  投资活动产生的现金流量净额-377,534,522.75-685,375,457.2-191,552,325.58-134,606,216.62
三、筹资活动产生的现金流量:
  吸收投资收到的现金04,000,0004,000,0004,000,000
  其中:子公司吸收少数股东投资收到的现金-4,000,000--
  取得借款收到的现金0114,800,000114,800,000114,800,000
  筹资活动现金流入小计0118,800,000118,800,000118,800,000
  偿还债务支付的现金500,0002,368,571.421,868,571.421,745,714.28
  分配股利、利润或偿付利息支付的现金556,914.581,481,244.51887,527.99303,205.68
  支付其他与筹资活动有关的现金1,254,380.88135,746,711.96133,250,168.01110,058,993.49
  筹资活动现金流出小计2,311,295.46139,596,527.89136,006,267.42112,107,913.45
  筹资活动产生的现金流量净额-2,311,295.46-20,796,527.89-17,206,267.426,692,086.55
四、汇率变动对现金及现金等价物的影响070.9370.9670.96
五、现金及现金等价物净增加额-363,759,348.72-701,449,431.04-182,347,372.23-100,111,169.73
  加:期初现金及现金等价物余额1,756,129,111.092,457,578,542.132,457,578,542.132,457,578,542.13
  期末现金及现金等价物余额1,392,369,762.371,756,129,111.092,275,231,169.92,357,467,372.4
补充资料:
  净利润--421,925,827.96--59,773,293.16
  资产减值准备-179,756,793.34-7,348,290.91
  固定资产和投资性房地产折旧-63,524,228.41-31,227,488.64
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-63,524,228.41-31,227,488.64
  无形资产摊销-20,521,007.66-10,126,848.82
  长期待摊费用摊销-18,266,939.23-4,810,231.37
  处置固定资产、无形资产和其他长期资产的损失--1,378,451.21--394.81
  固定资产报废损失-85,100.06-133,818.43
  公允价值变动损失--81,338.21--
  财务费用-29,998,457.29-563,578.02
  投资损失-27,869,182.51-10,238,855.34
  递延所得税--2,672,867.9-1,423,337.85
  其中:递延所得税资产减少-9,418,990.96-965,136.4
    递延所得税负债增加--12,091,858.86-458,201.45
  存货的减少-42,277,219.26--9,132,939.41
  经营性应收项目的减少--6,657,452.74-38,248,088.24
  经营性应付项目的增加--6,201,594.76--10,709,806.38
  债务转为资本-0--
  一年内到期的可转换公司债券-0--
  融资租入固定资产-0--
  现金的期末余额-1,756,129,111.09-2,357,467,372.4
  减:现金的期初余额-2,457,578,542.13-2,457,578,542.13
  加:现金等价物的期末余额-0--
  减:现金等价物的期初余额-0--
  现金及现金等价物的净增加额--701,449,431.04--100,111,169.73
公告日期2026-04-252026-04-252025-10-252025-08-23
审计意见(境内)标准无保留意见
TOP↑